Selecting Candidates for Organ‐Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics

Lijuan Wan,Zhuo Sun,Wenjing Peng,Sicong Wang,Jiangtao Li,Qing Zhao,Shuhao Wang,Han Ouyang,Xinming Zhao,Shuangmei Zou,Hongmei Zhang
DOI: https://doi.org/10.1002/jmri.28108
IF: 4.4
2022-02-10
Journal of Magnetic Resonance Imaging
Abstract:BACKGROUND: Histopathologic evaluation after surgery is the gold standard to evaluate treatment response to neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC). However, it cannot be used to guide organ-preserving strategies due to poor timeliness.PURPOSE: To develop and validate a multiscale model incorporating radiomics and pathomics features for predicting pathological good response (pGR) of down-staging to stage ypT0-1N0 after nCRT.STUDY TYPE: Retrospective.POPULATION: A total of 153 patients (median age, 55 years; 109 men; 107 training group; 46 validation group) with clinicopathologically confirmed LARC.FIELD STRENGTH/SEQUENCE: A 3.0-T; fast spin echo T<sub>2</sub> -weighted and single-shot EPI diffusion-weighted images.ASSESSMENT: The differences in clinicoradiological variables between pGR and non-pGR groups were assessed. Pretreatment and posttreatment radiomics signatures, and pathomics signature were constructed. A multiscale pGR prediction model was established. The predictive performance of the model was evaluated and compared to that of the clinicoradiological model.STATISTICAL TESTS: The χ<sup>2</sup> test, Fisher's exact test, t-test, the minimum redundancy maximum relevance algorithm, the least absolute shrinkage and selection operator logistic regression algorithm, regression analysis, receiver operating characteristic curve (ROC) analysis, Delong method. P &lt; 0.05 indicated a significant difference.RESULTS: Pretreatment radiomics signature (odds ratio [OR] = 2.53; 95% CI: 1.58-4.66), posttreatment radiomics signature (OR = 9.59; 95% CI: 3.04-41.46), and pathomics signature (OR = 3.14; 95% CI: 1.40-8.31) were independent factors for predicting pGR. The multiscale model presented good predictive performance with areas under the curve (AUC) of 0.93 (95% CI: 0.88-0.98) and 0.90 (95% CI: 0.78-1.00) in the training and validation groups, those were significantly higher than that of the clinicoradiological model with AUCs of 0.69 (95% CI: 0.55-0.82) and 0.68 (95% CI: 0.46-0.91) in both groups.DATA CONCLUSION: A model incorporating radiomics and pathomics features effectively predicted pGR after nCRT in patients with LARC.EVIDENCE LEVEL: 3 TECHNICAL EFFICACY: Stage 4.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?